Real-World Use of Insulin Glargine u100 and u300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: Dosinglar Study

Description

Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.

Date made available	24 May 2021
Publisher	Adis Journals

DOI
10.6084/m9.figshare.14535843

1 Article

Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study
Duque, N., Artime, E., Romera, I., Lebrec, J., Díaz, S., Rubio, M., Sicras-Mainar, A., Carretero-Anibarro, E., Mundet, X., Gorgojo-Martínez, J. J. & Reviriego, J., 29 May 2021, In: Advances in Therapy. 38, 7, p. 3857-3871 15 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
4 Citations (Scopus)

Cite this

Duque, N. (Creator), Artime, E. (Creator), Romera, I. (Creator), Lebrec, J. (Creator), Díaz, S. (Creator), Rubio, M. (Creator), Sicras-Mainar, A. (Creator), Carretero-Anibarro, E. (Creator), Mundet, X. (Creator), Gorgojo-Martínez, J. J. (Creator), Reviriego, J. (Creator) (24 May 2021). Real-World Use of Insulin Glargine u100 and u300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: Dosinglar Study. Adis Journals. 10.6084/m9.figshare.14535843